Retatrutide, developed by Soma Corp., is gaining considerable attention as a innovative method for weight control . This dual-action compound combines the activity of a GLP-1 receptor agonist and a GIP receptor agonist , designed to not only promote weight loss but also target underlying metabolic issues . Preliminary human data have indicated p… Read More